Detailansicht

Wissensnetz

Person

Laura Lotz (1987-)

Ärztin

Name	Laura Lotz
Zeit	1987- (Lebensdaten)
Ort	Bamberg (Geburtsort) Deutschland
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Dr. med. (an der Medizin. Fakultät der Univ. Erlangen-Nürnberg) (2014)
Beruf	Ärztin (charakteristischer Beruf)
Variante	Laura Maria Rosa Alice Lotz
Datensatztyp	Person
GND-Nummer	1067597956
Datensatz-ID	1067597956
Beteiligt an alle anzeigen Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) – Recommendations and Statements for Girls and Women Does stimulation with human gonadotropins and GnRH agonist enhance and accelerate the developmental capacity of oocytes in human ovarian tissue xenografted into SCID mice?

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Laura Lotz (1987-)

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy

Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) – Recommendations and Statements for Girls and Women

Does stimulation with human gonadotropins and GnRH agonist enhance and accelerate the developmental capacity of oocytes in human ovarian tissue xenografted into SCID mice?